Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Organizations
Organizations
Synthetic Genomics
Products 1 to 3 of 3
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Archetype: Sequence Genome Anotation Software
by
SGI-DNA
+
Synthetic Genomics
Biotech components:
N/A
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 16:59 (6 years ago)
Known funding amount:
40,000,000 USD
Funding types:
Venture Capital
Industry:
Science
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Design
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
BioXp 3200: Benchtop DNA Assembly
by
SGI-DNA
+
Synthetic Genomics
Biotech components:
N/A
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/19 16:02 (6 years ago)
Known funding amount:
40,000,000 USD
Funding types:
Venture Capital
Industry:
Science
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Design
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Humanized Pig Organs
by
Synthetic Genomics
+
United Therapeutics’ Lung Biotechnology Inc
Biotech components:
Animal
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 15:05 (6 years ago)
Known funding amount:
40,000,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
